Evidence map›Paper›PMID 38035802›Full record

ArticleThe Journal of clinical endocrinology and metabolism2024

Defective Visceral Adipose Tissue Adaptation in Gestational Diabetes Mellitus.

Colm J McElwain, Samprikta Manna, Andrea Musumeci, Isaac Sylvester, Chloé Rouchon, Anne Marie O'Callaghan, Mustafa Abdalla Bakhit Ebad, Fergus P McCarthy, Cathal M McCarthy

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Colm J McElwainDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
Samprikta MannaDepartment of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork T12DC4A, Ireland.
Andrea MusumeciDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
Isaac SylvesterDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
Chloé RouchonDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
Anne Marie O'CallaghanDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
Mustafa Abdalla Bakhit EbadDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.
Fergus P McCarthyDepartment of Obstetrics and Gynaecology, Cork University Maternity Hospital, Cork T12DC4A, Ireland.
Cathal M McCarthyDepartment of Pharmacology and Therapeutics, Western Gateway Building, University College Cork, Cork T12XF62, Ireland.ORCID 0000-0002-9514-9021
University College Cork · IECork University Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextGestational diabetes mellitus (GDM) is a complex obstetric condition affecting localized glucose metabolism, resulting in systemic metabolic dysfunction.

objectiveThis cross-sectional study aimed to explore visceral adipose tissue (VAT) as an integral contributor to GDM, focusing on elucidating the specific contribution of obesity and GDM pathology to maternal outcomes.

methodsFifty-six nulliparous pregnant women were recruited, including normal glucose tolerant (NGT) (n = 30) and GDM (n = 26) participants. Participants were subgrouped as nonobese (BMI <30 kg/m2) or obese (BMI ≥30 kg/m2). Metabolic markers in circulation, VAT, and placenta were determined. Morphological analysis of VAT and immunoblotting of the insulin signaling cascade were performed.

resultsGDM participants demonstrated hyperinsulinemia and elevated homeostatic model assessment for insulin resistance (HOMA-IR) scores relative to NGT participants. The GDM-obese subgroup had significant VAT adipocyte hypoplasia relative to NGT-nonobese tissue. GDM-obese VAT had significantly lower insulin receptor substrate (IRS)-2 expression, with elevated ser312 phosphorylation of IRS-1, relative to NGT-nonobese. GDM-obese participants had significantly elevated circulating leptin levels and placental adipsin secretion, while GDM-nonobese participants had elevated circulating adipsin levels with reduced placental adiponectin secretion.

conclusionThese findings suggest that GDM-obese pregnancy is specifically characterized by inadequate VAT remodeling and dysfunctional molecular signaling, which contribute to insulin resistance and hinder metabolic health.

Indexed as

Diabetes, GestationalInsulin ResistanceAdipose TissueComplement Factor DCross-Sectional StudiesFemaleHumansInsulinIntra-Abdominal FatObesityPlacentaPregnancyComplement Factor DInsulinadipogenesisendocrinologygestational diabetes mellitus (GDM)insulin resistanceinsulin signalingvisceral adipose tissue (VAT)

Identifiers

PMID38035802
PMCPMC11031241
OpenAlexW4389208235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.